Clinical Trials Browser

Phase 2 × saracatinib × Genitourinary × Clear all

NCT00513071 2018-04-19

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

28 enrolled 9 charts

Prostatic Neoplasms

NCT01267266 2015-04-01

Saracatinib in Treating Patients With Prostate Cancer

Phase 2 Terminated

31 enrolled 6 charts

Prostatic Neoplasms